nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—attention deficit hyperactivity disorder—Clonidine—glaucoma	0.486	1	CpDpCtD
Dextroamphetamine—ADRA1A—Apraclonidine—glaucoma	0.0796	0.228	CbGbCtD
Dextroamphetamine—ADRA1A—Dipivefrin—glaucoma	0.0636	0.182	CbGbCtD
Dextroamphetamine—ADRA1B—Clonidine—glaucoma	0.0419	0.12	CbGbCtD
Dextroamphetamine—SLC6A2—Clonidine—glaucoma	0.0382	0.11	CbGbCtD
Dextroamphetamine—ADRA1A—Clonidine—glaucoma	0.033	0.0946	CbGbCtD
Dextroamphetamine—CYP2D6—Carteolol—glaucoma	0.031	0.0887	CbGbCtD
Dextroamphetamine—CYP2D6—Betaxolol—glaucoma	0.0209	0.0599	CbGbCtD
Dextroamphetamine—CYP2D6—Methazolamide—glaucoma	0.0159	0.0454	CbGbCtD
Dextroamphetamine—CYP2D6—Timolol—glaucoma	0.0135	0.0386	CbGbCtD
Dextroamphetamine—CYP2D6—Clonidine—glaucoma	0.0115	0.0328	CbGbCtD
Dextroamphetamine—SLC18A2—Dopaminergic Neurogenesis—LMX1B—glaucoma	0.00254	0.0683	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00165	0.0444	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Dopaminergic Neurogenesis—LMX1B—glaucoma	0.00152	0.0407	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.00121	0.0325	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Amine compound SLC transporters—SLC6A13—glaucoma	0.00115	0.0308	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00111	0.0299	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.000985	0.0265	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Neurotransmitter Release Cycle—SLC6A13—glaucoma	0.000876	0.0235	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Amine compound SLC transporters—SLC6A1—glaucoma	0.000839	0.0225	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.000814	0.0219	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Amine compound SLC transporters—SLC6A13—glaucoma	0.000772	0.0207	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.000721	0.0194	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Amine compound SLC transporters—SLC6A13—glaucoma	0.000684	0.0184	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Neurotransmitter Release Cycle—SLC6A1—glaucoma	0.000641	0.0172	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Amine compound SLC transporters—SLC6A1—glaucoma	0.000565	0.0152	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Monoamine Transport—SLC6A1—glaucoma	0.000536	0.0144	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Amine compound SLC transporters—SLC6A1—glaucoma	0.0005	0.0134	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Endothelin Pathways—MYLK—glaucoma	0.000499	0.0134	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000494	0.0133	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Monoamine Transport—SLC6A1—glaucoma	0.000475	0.0128	CbGpPWpGaD
Dextroamphetamine—Lacosamide—CA1—glaucoma	0.000473	0.446	CrCbGaD
Dextroamphetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000448	0.012	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000445	0.012	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—OPN4—glaucoma	0.000376	0.0101	CbGpPWpGaD
Dextroamphetamine—Lacosamide—CA2—glaucoma	0.000359	0.338	CrCbGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—PTGFR—glaucoma	0.000339	0.0091	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000328	0.00882	CbGpPWpGaD
Dextroamphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000305	0.0082	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000302	0.0081	CbGpPWpGaD
Dextroamphetamine—ADRA1B—AMPK Signaling—RPTOR—glaucoma	0.000295	0.00793	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000267	0.00718	CbGpPWpGaD
Dextroamphetamine—ADRA1A—AMPK Signaling—RPTOR—glaucoma	0.000262	0.00705	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000251	0.00675	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.00023	0.00617	CbGpPWpGaD
Dextroamphetamine—Pseudoephedrine—TNF—glaucoma	0.000229	0.216	CrCbGaD
Dextroamphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000221	0.00593	CbGpPWpGaD
Dextroamphetamine—Nausea—Carteolol—glaucoma	0.00022	0.00174	CcSEcCtD
Dextroamphetamine—Headache—Levobunolol—glaucoma	0.000219	0.00173	CcSEcCtD
Dextroamphetamine—Depression—Betaxolol—glaucoma	0.000219	0.00173	CcSEcCtD
Dextroamphetamine—Chest pain—Brinzolamide—glaucoma	0.000218	0.00173	CcSEcCtD
Dextroamphetamine—Palpitations—Pilocarpine—glaucoma	0.000218	0.00172	CcSEcCtD
Dextroamphetamine—SLC6A2—NRF2 pathway—SLC6A13—glaucoma	0.000218	0.00584	CbGpPWpGaD
Dextroamphetamine—Tachycardia—Brimonidine—glaucoma	0.000217	0.00172	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000217	0.00172	CcSEcCtD
Dextroamphetamine—Dry mouth—Dorzolamide—glaucoma	0.000217	0.00172	CcSEcCtD
Dextroamphetamine—Nausea—Diclofenamide—glaucoma	0.000216	0.00171	CcSEcCtD
Dextroamphetamine—Dry mouth—Travoprost—glaucoma	0.000216	0.00171	CcSEcCtD
Dextroamphetamine—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	0.000216	0.0058	CbGpPWpGaD
Dextroamphetamine—Acute coronary syndrome—Betaxolol—glaucoma	0.000216	0.00171	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Betaxolol—glaucoma	0.000215	0.0017	CcSEcCtD
Dextroamphetamine—Dizziness—Latanoprost—glaucoma	0.000215	0.0017	CcSEcCtD
Dextroamphetamine—Dry mouth—Brinzolamide—glaucoma	0.000213	0.00169	CcSEcCtD
Dextroamphetamine—Vomiting—Methazolamide—glaucoma	0.000213	0.00169	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Dorzolamide—glaucoma	0.000213	0.00168	CcSEcCtD
Dextroamphetamine—Hypertension—Pilocarpine—glaucoma	0.000213	0.00168	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR downstream signaling—OPN4—glaucoma	0.000213	0.00571	CbGpPWpGaD
Dextroamphetamine—Gastrointestinal pain—Apraclonidine—glaucoma	0.000212	0.00168	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Timolol—glaucoma	0.000212	0.00168	CcSEcCtD
Dextroamphetamine—Rash—Methazolamide—glaucoma	0.000211	0.00167	CcSEcCtD
Dextroamphetamine—Dermatitis—Methazolamide—glaucoma	0.000211	0.00167	CcSEcCtD
Dextroamphetamine—Nausea—Carbachol—glaucoma	0.000211	0.00167	CcSEcCtD
Dextroamphetamine—Infection—Travoprost—glaucoma	0.00021	0.00166	CcSEcCtD
Dextroamphetamine—Sweating—Betaxolol—glaucoma	0.00021	0.00166	CcSEcCtD
Dextroamphetamine—Headache—Methazolamide—glaucoma	0.00021	0.00166	CcSEcCtD
Dextroamphetamine—Chest pain—Pilocarpine—glaucoma	0.00021	0.00166	CcSEcCtD
Dextroamphetamine—Anxiety—Pilocarpine—glaucoma	0.000209	0.00165	CcSEcCtD
Dextroamphetamine—Nausea—Levobunolol—glaucoma	0.000208	0.00164	CcSEcCtD
Dextroamphetamine—Infection—Brinzolamide—glaucoma	0.000208	0.00164	CcSEcCtD
Dextroamphetamine—SLC6A3—Alpha-synuclein signaling—BAD—glaucoma	0.000207	0.00556	CbGpPWpGaD
Dextroamphetamine—Tachycardia—Travoprost—glaucoma	0.000207	0.00163	CcSEcCtD
Dextroamphetamine—Somnolence—Acetazolamide—glaucoma	0.000206	0.00163	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Dorzolamide—glaucoma	0.000206	0.00163	CcSEcCtD
Dextroamphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000206	0.00552	CbGpPWpGaD
Dextroamphetamine—Abdominal pain—Apraclonidine—glaucoma	0.000205	0.00162	CcSEcCtD
Dextroamphetamine—Rash—Latanoprost—glaucoma	0.000205	0.00162	CcSEcCtD
Dextroamphetamine—Dermatitis—Latanoprost—glaucoma	0.000205	0.00162	CcSEcCtD
Dextroamphetamine—Dyspepsia—Acetazolamide—glaucoma	0.000204	0.00162	CcSEcCtD
Dextroamphetamine—Tachycardia—Brinzolamide—glaucoma	0.000204	0.00161	CcSEcCtD
Dextroamphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000204	0.00547	CbGpPWpGaD
Dextroamphetamine—Headache—Latanoprost—glaucoma	0.000203	0.00161	CcSEcCtD
Dextroamphetamine—Anorexia—Dorzolamide—glaucoma	0.000203	0.0016	CcSEcCtD
Dextroamphetamine—Decreased appetite—Acetazolamide—glaucoma	0.000202	0.0016	CcSEcCtD
Dextroamphetamine—Insomnia—Brimonidine—glaucoma	0.000202	0.00159	CcSEcCtD
Dextroamphetamine—ADRA1A—Endothelin Pathways—EDN1—glaucoma	0.000201	0.0054	CbGpPWpGaD
Dextroamphetamine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.0002	0.00158	CcSEcCtD
Dextroamphetamine—Fatigue—Acetazolamide—glaucoma	0.0002	0.00158	CcSEcCtD
Dextroamphetamine—Infection—Pilocarpine—glaucoma	0.0002	0.00158	CcSEcCtD
Dextroamphetamine—Nausea—Methazolamide—glaucoma	0.000199	0.00157	CcSEcCtD
Dextroamphetamine—Dyspnoea—Brimonidine—glaucoma	0.000199	0.00157	CcSEcCtD
Dextroamphetamine—Somnolence—Brimonidine—glaucoma	0.000198	0.00157	CcSEcCtD
Dextroamphetamine—Tachycardia—Pilocarpine—glaucoma	0.000196	0.00155	CcSEcCtD
Dextroamphetamine—Dyspepsia—Brimonidine—glaucoma	0.000196	0.00155	CcSEcCtD
Dextroamphetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000196	0.00526	CbGpPWpGaD
Dextroamphetamine—Hyperhidrosis—Pilocarpine—glaucoma	0.000194	0.00154	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—OPN4—glaucoma	0.000193	0.00519	CbGpPWpGaD
Dextroamphetamine—Tension—Clonidine—glaucoma	0.000193	0.00153	CcSEcCtD
Dextroamphetamine—SLC6A3—NRF2 pathway—SLC6A13—glaucoma	0.000193	0.00518	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Neuronal System—SLC6A13—glaucoma	0.000193	0.00517	CbGpPWpGaD
Dextroamphetamine—Insomnia—Dorzolamide—glaucoma	0.000192	0.00152	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000192	0.00152	CcSEcCtD
Dextroamphetamine—Fatigue—Brimonidine—glaucoma	0.000192	0.00152	CcSEcCtD
Dextroamphetamine—Anorexia—Pilocarpine—glaucoma	0.000192	0.00152	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR downstream signaling—PTGFR—glaucoma	0.000192	0.00514	CbGpPWpGaD
Dextroamphetamine—Hypersensitivity—Apraclonidine—glaucoma	0.000191	0.00151	CcSEcCtD
Dextroamphetamine—Nervousness—Clonidine—glaucoma	0.000191	0.00151	CcSEcCtD
Dextroamphetamine—Dyspnoea—Dorzolamide—glaucoma	0.00019	0.0015	CcSEcCtD
Dextroamphetamine—Insomnia—Brinzolamide—glaucoma	0.000189	0.0015	CcSEcCtD
Dextroamphetamine—Somnolence—Dorzolamide—glaucoma	0.000189	0.0015	CcSEcCtD
Dextroamphetamine—Dyspnoea—Travoprost—glaucoma	0.000189	0.00149	CcSEcCtD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—OPN4—glaucoma	0.000189	0.00507	CbGpPWpGaD
Dextroamphetamine—Dyspepsia—Dorzolamide—glaucoma	0.000187	0.00148	CcSEcCtD
Dextroamphetamine—Dyspnoea—Brinzolamide—glaucoma	0.000187	0.00147	CcSEcCtD
Dextroamphetamine—Dyspepsia—Travoprost—glaucoma	0.000187	0.00147	CcSEcCtD
Dextroamphetamine—Asthenia—Apraclonidine—glaucoma	0.000186	0.00147	CcSEcCtD
Dextroamphetamine—Somnolence—Brinzolamide—glaucoma	0.000186	0.00147	CcSEcCtD
Dextroamphetamine—Decreased appetite—Dorzolamide—glaucoma	0.000185	0.00146	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Timolol—glaucoma	0.000185	0.00146	CcSEcCtD
Dextroamphetamine—Urticaria—Acetazolamide—glaucoma	0.000184	0.00146	CcSEcCtD
Dextroamphetamine—Tremor—Clonidine—glaucoma	0.000184	0.00146	CcSEcCtD
Dextroamphetamine—Dyspepsia—Brinzolamide—glaucoma	0.000184	0.00146	CcSEcCtD
Dextroamphetamine—SLC18A2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000184	0.00494	CbGpPWpGaD
Dextroamphetamine—Body temperature increased—Acetazolamide—glaucoma	0.000184	0.00145	CcSEcCtD
Dextroamphetamine—Fatigue—Dorzolamide—glaucoma	0.000183	0.00145	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Travoprost—glaucoma	0.000183	0.00145	CcSEcCtD
Dextroamphetamine—Fatigue—Travoprost—glaucoma	0.000183	0.00144	CcSEcCtD
Dextroamphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000182	0.00489	CbGpPWpGaD
Dextroamphetamine—Insomnia—Pilocarpine—glaucoma	0.000182	0.00144	CcSEcCtD
Dextroamphetamine—Decreased appetite—Brinzolamide—glaucoma	0.000182	0.00144	CcSEcCtD
Dextroamphetamine—Weight decreased—Timolol—glaucoma	0.000182	0.00144	CcSEcCtD
Dextroamphetamine—Constipation—Travoprost—glaucoma	0.000181	0.00143	CcSEcCtD
Dextroamphetamine—Agitation—Clonidine—glaucoma	0.000181	0.00143	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000181	0.00143	CcSEcCtD
Dextroamphetamine—Asthenia—Bimatoprost—glaucoma	0.000181	0.00143	CcSEcCtD
Dextroamphetamine—Fatigue—Brinzolamide—glaucoma	0.00018	0.00143	CcSEcCtD
Dextroamphetamine—Angioedema—Clonidine—glaucoma	0.00018	0.00142	CcSEcCtD
Dextroamphetamine—Dyspnoea—Pilocarpine—glaucoma	0.000179	0.00142	CcSEcCtD
Dextroamphetamine—Somnolence—Pilocarpine—glaucoma	0.000179	0.00141	CcSEcCtD
Dextroamphetamine—SLC6A2—NRF2 pathway—TXN—glaucoma	0.000179	0.0048	CbGpPWpGaD
Dextroamphetamine—Depression—Timolol—glaucoma	0.000179	0.00141	CcSEcCtD
Dextroamphetamine—Diarrhoea—Apraclonidine—glaucoma	0.000178	0.0014	CcSEcCtD
Dextroamphetamine—Dyspepsia—Pilocarpine—glaucoma	0.000177	0.0014	CcSEcCtD
Dextroamphetamine—Decreased appetite—Pilocarpine—glaucoma	0.000175	0.00138	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000174	0.00138	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—PTGFR—glaucoma	0.000174	0.00467	CbGpPWpGaD
Dextroamphetamine—Palpitations—Clonidine—glaucoma	0.000174	0.00137	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000174	0.00137	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Travoprost—glaucoma	0.000173	0.00137	CcSEcCtD
Dextroamphetamine—Constipation—Pilocarpine—glaucoma	0.000172	0.00136	CcSEcCtD
Dextroamphetamine—Sweating—Timolol—glaucoma	0.000172	0.00136	CcSEcCtD
Dextroamphetamine—Dizziness—Apraclonidine—glaucoma	0.000172	0.00136	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—SMO—glaucoma	0.000171	0.00459	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—PTGFR—glaucoma	0.00017	0.00457	CbGpPWpGaD
Dextroamphetamine—Urticaria—Dorzolamide—glaucoma	0.000169	0.00134	CcSEcCtD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.000169	0.00454	CbGpPWpGaD
Dextroamphetamine—Body temperature increased—Dorzolamide—glaucoma	0.000168	0.00133	CcSEcCtD
Dextroamphetamine—Abdominal pain—Dorzolamide—glaucoma	0.000168	0.00133	CcSEcCtD
Dextroamphetamine—Tension—Betaxolol—glaucoma	0.000168	0.00133	CcSEcCtD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—OPN4—glaucoma	0.000168	0.0045	CbGpPWpGaD
Dextroamphetamine—Chest pain—Clonidine—glaucoma	0.000167	0.00132	CcSEcCtD
Dextroamphetamine—Abdominal pain—Travoprost—glaucoma	0.000167	0.00132	CcSEcCtD
Dextroamphetamine—Anxiety—Clonidine—glaucoma	0.000167	0.00132	CcSEcCtD
Dextroamphetamine—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000167	0.00448	CbGpPWpGaD
Dextroamphetamine—Asthenia—Acetazolamide—glaucoma	0.000167	0.00132	CcSEcCtD
Dextroamphetamine—Dizziness—Bimatoprost—glaucoma	0.000166	0.00132	CcSEcCtD
Dextroamphetamine—Nervousness—Betaxolol—glaucoma	0.000166	0.00132	CcSEcCtD
Dextroamphetamine—Urticaria—Brinzolamide—glaucoma	0.000166	0.00131	CcSEcCtD
Dextroamphetamine—Vomiting—Apraclonidine—glaucoma	0.000165	0.0013	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling Pathways—LRP12—glaucoma	0.000165	0.00442	CbGpPWpGaD
Dextroamphetamine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000164	0.0013	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Brimonidine—glaucoma	0.000164	0.0013	CcSEcCtD
Dextroamphetamine—Dry mouth—Clonidine—glaucoma	0.000164	0.0013	CcSEcCtD
Dextroamphetamine—Dermatitis—Apraclonidine—glaucoma	0.000163	0.00129	CcSEcCtD
Dextroamphetamine—Headache—Apraclonidine—glaucoma	0.000163	0.00129	CcSEcCtD
Dextroamphetamine—Tremor—Betaxolol—glaucoma	0.00016	0.00127	CcSEcCtD
Dextroamphetamine—Asthenia—Brimonidine—glaucoma	0.00016	0.00126	CcSEcCtD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00016	0.00429	CbGpPWpGaD
Dextroamphetamine—Infection—Clonidine—glaucoma	0.00016	0.00126	CcSEcCtD
Dextroamphetamine—SLC6A2—NRF2 pathway—SLC6A1—glaucoma	0.000159	0.00428	CbGpPWpGaD
Dextroamphetamine—Body temperature increased—Pilocarpine—glaucoma	0.000159	0.00126	CcSEcCtD
Dextroamphetamine—Abdominal pain—Pilocarpine—glaucoma	0.000159	0.00126	CcSEcCtD
Dextroamphetamine—Diarrhoea—Acetazolamide—glaucoma	0.000159	0.00126	CcSEcCtD
Dextroamphetamine—Rash—Bimatoprost—glaucoma	0.000159	0.00125	CcSEcCtD
Dextroamphetamine—Dermatitis—Bimatoprost—glaucoma	0.000159	0.00125	CcSEcCtD
Dextroamphetamine—SLC6A3—NRF2 pathway—TXN—glaucoma	0.000158	0.00425	CbGpPWpGaD
Dextroamphetamine—Headache—Bimatoprost—glaucoma	0.000158	0.00125	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Dorzolamide—glaucoma	0.000157	0.00124	CcSEcCtD
Dextroamphetamine—Tachycardia—Clonidine—glaucoma	0.000157	0.00124	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Travoprost—glaucoma	0.000156	0.00123	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Clonidine—glaucoma	0.000155	0.00123	CcSEcCtD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000155	0.00417	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000155	0.00415	CbGpPWpGaD
Dextroamphetamine—Nausea—Apraclonidine—glaucoma	0.000154	0.00122	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Brinzolamide—glaucoma	0.000154	0.00122	CcSEcCtD
Dextroamphetamine—Dizziness—Acetazolamide—glaucoma	0.000154	0.00121	CcSEcCtD
Dextroamphetamine—Anorexia—Clonidine—glaucoma	0.000153	0.00121	CcSEcCtD
Dextroamphetamine—Asthenia—Dorzolamide—glaucoma	0.000153	0.00121	CcSEcCtD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000152	0.00408	CbGpPWpGaD
Dextroamphetamine—Asthenia—Travoprost—glaucoma	0.000152	0.0012	CcSEcCtD
Dextroamphetamine—Palpitations—Betaxolol—glaucoma	0.000151	0.0012	CcSEcCtD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—PTGFR—glaucoma	0.000151	0.00406	CbGpPWpGaD
Dextroamphetamine—Asthenia—Brinzolamide—glaucoma	0.00015	0.00119	CcSEcCtD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00015	0.00403	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.00015	0.00402	CbGpPWpGaD
Dextroamphetamine—Nausea—Bimatoprost—glaucoma	0.000149	0.00118	CcSEcCtD
Dextroamphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000149	0.00401	CbGpPWpGaD
Dextroamphetamine—Hypersensitivity—Pilocarpine—glaucoma	0.000148	0.00117	CcSEcCtD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000148	0.00397	CbGpPWpGaD
Dextroamphetamine—Vomiting—Acetazolamide—glaucoma	0.000148	0.00117	CcSEcCtD
Dextroamphetamine—Dizziness—Brimonidine—glaucoma	0.000147	0.00116	CcSEcCtD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000146	0.00392	CbGpPWpGaD
Dextroamphetamine—Chest pain—Betaxolol—glaucoma	0.000146	0.00115	CcSEcCtD
Dextroamphetamine—Diarrhoea—Dorzolamide—glaucoma	0.000146	0.00115	CcSEcCtD
Dextroamphetamine—Headache—Acetazolamide—glaucoma	0.000145	0.00115	CcSEcCtD
Dextroamphetamine—Anxiety—Betaxolol—glaucoma	0.000145	0.00115	CcSEcCtD
Dextroamphetamine—Insomnia—Clonidine—glaucoma	0.000145	0.00115	CcSEcCtD
Dextroamphetamine—Diarrhoea—Travoprost—glaucoma	0.000145	0.00115	CcSEcCtD
Dextroamphetamine—Asthenia—Pilocarpine—glaucoma	0.000144	0.00114	CcSEcCtD
Dextroamphetamine—Dyspnoea—Clonidine—glaucoma	0.000143	0.00113	CcSEcCtD
Dextroamphetamine—Diarrhoea—Brinzolamide—glaucoma	0.000143	0.00113	CcSEcCtD
Dextroamphetamine—Somnolence—Clonidine—glaucoma	0.000143	0.00113	CcSEcCtD
Dextroamphetamine—Dry mouth—Betaxolol—glaucoma	0.000143	0.00113	CcSEcCtD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000142	0.00381	CbGpPWpGaD
Dextroamphetamine—SLC6A3—NRF2 pathway—SLC6A1—glaucoma	0.000141	0.00379	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Neuronal System—SLC6A1—glaucoma	0.000141	0.00379	CbGpPWpGaD
Dextroamphetamine—Dizziness—Dorzolamide—glaucoma	0.000141	0.00111	CcSEcCtD
Dextroamphetamine—Rash—Brimonidine—glaucoma	0.00014	0.00111	CcSEcCtD
Dextroamphetamine—Dermatitis—Brimonidine—glaucoma	0.00014	0.00111	CcSEcCtD
Dextroamphetamine—Dizziness—Travoprost—glaucoma	0.00014	0.00111	CcSEcCtD
Dextroamphetamine—Headache—Brimonidine—glaucoma	0.00014	0.0011	CcSEcCtD
Dextroamphetamine—Decreased appetite—Clonidine—glaucoma	0.00014	0.0011	CcSEcCtD
Dextroamphetamine—Infection—Betaxolol—glaucoma	0.000139	0.0011	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Clonidine—glaucoma	0.000139	0.0011	CcSEcCtD
Dextroamphetamine—Fatigue—Clonidine—glaucoma	0.000138	0.00109	CcSEcCtD
Dextroamphetamine—Dizziness—Brinzolamide—glaucoma	0.000138	0.00109	CcSEcCtD
Dextroamphetamine—Nausea—Acetazolamide—glaucoma	0.000138	0.00109	CcSEcCtD
Dextroamphetamine—Diarrhoea—Pilocarpine—glaucoma	0.000138	0.00109	CcSEcCtD
Dextroamphetamine—Tension—Timolol—glaucoma	0.000137	0.00109	CcSEcCtD
Dextroamphetamine—Constipation—Clonidine—glaucoma	0.000137	0.00109	CcSEcCtD
Dextroamphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000137	0.00368	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—PEX19—glaucoma	0.000137	0.00368	CbGpPWpGaD
Dextroamphetamine—Tachycardia—Betaxolol—glaucoma	0.000136	0.00108	CcSEcCtD
Dextroamphetamine—Nervousness—Timolol—glaucoma	0.000136	0.00107	CcSEcCtD
Dextroamphetamine—Vomiting—Dorzolamide—glaucoma	0.000135	0.00107	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Betaxolol—glaucoma	0.000135	0.00107	CcSEcCtD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000135	0.00363	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	0.000135	0.00363	CbGpPWpGaD
Dextroamphetamine—Rash—Dorzolamide—glaucoma	0.000134	0.00106	CcSEcCtD
Dextroamphetamine—Dermatitis—Dorzolamide—glaucoma	0.000134	0.00106	CcSEcCtD
Dextroamphetamine—Rash—Travoprost—glaucoma	0.000134	0.00106	CcSEcCtD
Dextroamphetamine—Dermatitis—Travoprost—glaucoma	0.000133	0.00106	CcSEcCtD
Dextroamphetamine—Headache—Dorzolamide—glaucoma	0.000133	0.00105	CcSEcCtD
Dextroamphetamine—Anorexia—Betaxolol—glaucoma	0.000133	0.00105	CcSEcCtD
Dextroamphetamine—Vomiting—Brinzolamide—glaucoma	0.000133	0.00105	CcSEcCtD
Dextroamphetamine—Dizziness—Pilocarpine—glaucoma	0.000133	0.00105	CcSEcCtD
Dextroamphetamine—Headache—Travoprost—glaucoma	0.000133	0.00105	CcSEcCtD
Dextroamphetamine—Nausea—Brimonidine—glaucoma	0.000132	0.00105	CcSEcCtD
Dextroamphetamine—Rash—Brinzolamide—glaucoma	0.000132	0.00104	CcSEcCtD
Dextroamphetamine—Dermatitis—Brinzolamide—glaucoma	0.000132	0.00104	CcSEcCtD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000131	0.00353	CbGpPWpGaD
Dextroamphetamine—Gastrointestinal pain—Clonidine—glaucoma	0.000131	0.00104	CcSEcCtD
Dextroamphetamine—Headache—Brinzolamide—glaucoma	0.000131	0.00104	CcSEcCtD
Dextroamphetamine—SLC6A2—NRF2 pathway—TGFB2—glaucoma	0.00013	0.00349	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00013	0.00348	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000129	0.00347	CbGpPWpGaD
Dextroamphetamine—Angioedema—Timolol—glaucoma	0.000128	0.00101	CcSEcCtD
Dextroamphetamine—Vomiting—Pilocarpine—glaucoma	0.000128	0.00101	CcSEcCtD
Dextroamphetamine—Urticaria—Clonidine—glaucoma	0.000128	0.00101	CcSEcCtD
Dextroamphetamine—Abdominal pain—Clonidine—glaucoma	0.000127	0.001	CcSEcCtD
Dextroamphetamine—Body temperature increased—Clonidine—glaucoma	0.000127	0.001	CcSEcCtD
Dextroamphetamine—Rash—Pilocarpine—glaucoma	0.000127	0.001	CcSEcCtD
Dextroamphetamine—Dermatitis—Pilocarpine—glaucoma	0.000127	0.001	CcSEcCtD
Dextroamphetamine—Insomnia—Betaxolol—glaucoma	0.000126	0.001	CcSEcCtD
Dextroamphetamine—Nausea—Dorzolamide—glaucoma	0.000126	0.000999	CcSEcCtD
Dextroamphetamine—Headache—Pilocarpine—glaucoma	0.000126	0.000996	CcSEcCtD
Dextroamphetamine—Nausea—Travoprost—glaucoma	0.000126	0.000995	CcSEcCtD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000125	0.00336	CbGpPWpGaD
Dextroamphetamine—Dyspnoea—Betaxolol—glaucoma	0.000125	0.000985	CcSEcCtD
Dextroamphetamine—Nausea—Brinzolamide—glaucoma	0.000124	0.000982	CcSEcCtD
Dextroamphetamine—Palpitations—Timolol—glaucoma	0.000124	0.000978	CcSEcCtD
Dextroamphetamine—Dyspepsia—Betaxolol—glaucoma	0.000123	0.000973	CcSEcCtD
Dextroamphetamine—ADRA1A—Endothelin Pathways—NOS3—glaucoma	0.000123	0.00329	CbGpPWpGaD
Dextroamphetamine—Decreased appetite—Betaxolol—glaucoma	0.000122	0.000961	CcSEcCtD
Dextroamphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000121	0.00326	CbGpPWpGaD
Dextroamphetamine—Hypertension—Timolol—glaucoma	0.000121	0.000955	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000121	0.000954	CcSEcCtD
Dextroamphetamine—Fatigue—Betaxolol—glaucoma	0.000121	0.000953	CcSEcCtD
Dextroamphetamine—Constipation—Betaxolol—glaucoma	0.00012	0.000945	CcSEcCtD
Dextroamphetamine—Nausea—Pilocarpine—glaucoma	0.000119	0.000944	CcSEcCtD
Dextroamphetamine—Chest pain—Timolol—glaucoma	0.000119	0.000942	CcSEcCtD
Dextroamphetamine—Anxiety—Timolol—glaucoma	0.000119	0.000939	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Clonidine—glaucoma	0.000118	0.000935	CcSEcCtD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000117	0.00313	CbGpPWpGaD
Dextroamphetamine—Dry mouth—Timolol—glaucoma	0.000117	0.000921	CcSEcCtD
Dextroamphetamine—Asthenia—Clonidine—glaucoma	0.000115	0.000911	CcSEcCtD
Dextroamphetamine—SLC6A3—NRF2 pathway—TGFB2—glaucoma	0.000115	0.00309	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—SLC6A13—glaucoma	0.000115	0.00308	CbGpPWpGaD
Dextroamphetamine—Anaphylactic shock—Timolol—glaucoma	0.000114	0.000903	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling Pathways—OPN4—glaucoma	0.000114	0.00306	CbGpPWpGaD
Dextroamphetamine—Infection—Timolol—glaucoma	0.000113	0.000897	CcSEcCtD
Dextroamphetamine—SLC6A2—Monoamine Transport—TNF—glaucoma	0.000113	0.00304	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—EDN1—glaucoma	0.000113	0.00303	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000113	0.00302	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000111	0.00298	CbGpPWpGaD
Dextroamphetamine—Urticaria—Betaxolol—glaucoma	0.000111	0.000878	CcSEcCtD
Dextroamphetamine—Body temperature increased—Betaxolol—glaucoma	0.000111	0.000874	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Timolol—glaucoma	0.00011	0.000873	CcSEcCtD
Dextroamphetamine—Diarrhoea—Clonidine—glaucoma	0.00011	0.000869	CcSEcCtD
Dextroamphetamine—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	0.00011	0.00295	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.00011	0.00295	CbGpPWpGaD
Dextroamphetamine—Anorexia—Timolol—glaucoma	0.000109	0.000861	CcSEcCtD
Dextroamphetamine—Dizziness—Clonidine—glaucoma	0.000106	0.000839	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling Pathways—HEYL—glaucoma	0.000106	0.00285	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000104	0.0028	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000104	0.00278	CbGpPWpGaD
Dextroamphetamine—Insomnia—Timolol—glaucoma	0.000103	0.000817	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Betaxolol—glaucoma	0.000103	0.000814	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling Pathways—PTGFR—glaucoma	0.000103	0.00276	CbGpPWpGaD
Dextroamphetamine—Vomiting—Clonidine—glaucoma	0.000102	0.000807	CcSEcCtD
Dextroamphetamine—Dyspnoea—Timolol—glaucoma	0.000102	0.000805	CcSEcCtD
Dextroamphetamine—Somnolence—Timolol—glaucoma	0.000102	0.000803	CcSEcCtD
Dextroamphetamine—Rash—Clonidine—glaucoma	0.000101	0.0008	CcSEcCtD
Dextroamphetamine—Dermatitis—Clonidine—glaucoma	0.000101	0.0008	CcSEcCtD
Dextroamphetamine—Headache—Clonidine—glaucoma	0.000101	0.000795	CcSEcCtD
Dextroamphetamine—Dyspepsia—Timolol—glaucoma	0.000101	0.000795	CcSEcCtD
Dextroamphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.0001	0.0027	CbGpPWpGaD
Dextroamphetamine—Asthenia—Betaxolol—glaucoma	0.0001	0.000793	CcSEcCtD
Dextroamphetamine—SLC6A3—Monoamine Transport—TNF—glaucoma	0.0001	0.00269	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.0001	0.00269	CbGpPWpGaD
Dextroamphetamine—Decreased appetite—Timolol—glaucoma	9.93e-05	0.000785	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Timolol—glaucoma	9.86e-05	0.000779	CcSEcCtD
Dextroamphetamine—Fatigue—Timolol—glaucoma	9.85e-05	0.000778	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—C3—glaucoma	9.84e-05	0.00264	CbGpPWpGaD
Dextroamphetamine—Diarrhoea—Betaxolol—glaucoma	9.56e-05	0.000756	CcSEcCtD
Dextroamphetamine—Nausea—Clonidine—glaucoma	9.54e-05	0.000754	CcSEcCtD
Dextroamphetamine—ADRA1B—GPCR ligand binding—OPN4—glaucoma	9.52e-05	0.00256	CbGpPWpGaD
Dextroamphetamine—Gastrointestinal pain—Timolol—glaucoma	9.34e-05	0.000738	CcSEcCtD
Dextroamphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	9.33e-05	0.00251	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC4A4—glaucoma	9.25e-05	0.00248	CbGpPWpGaD
Dextroamphetamine—Dizziness—Betaxolol—glaucoma	9.24e-05	0.000731	CcSEcCtD
Dextroamphetamine—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	9.21e-05	0.00247	CbGpPWpGaD
Dextroamphetamine—Urticaria—Timolol—glaucoma	9.07e-05	0.000717	CcSEcCtD
Dextroamphetamine—Body temperature increased—Timolol—glaucoma	9.03e-05	0.000714	CcSEcCtD
Dextroamphetamine—Abdominal pain—Timolol—glaucoma	9.03e-05	0.000714	CcSEcCtD
Dextroamphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	8.89e-05	0.00239	CbGpPWpGaD
Dextroamphetamine—Vomiting—Betaxolol—glaucoma	8.89e-05	0.000703	CcSEcCtD
Dextroamphetamine—SLC6A2—NRF2 pathway—GSTM1—glaucoma	8.82e-05	0.00237	CbGpPWpGaD
Dextroamphetamine—Rash—Betaxolol—glaucoma	8.81e-05	0.000697	CcSEcCtD
Dextroamphetamine—Dermatitis—Betaxolol—glaucoma	8.81e-05	0.000696	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—SMO—glaucoma	8.77e-05	0.00236	CbGpPWpGaD
Dextroamphetamine—Headache—Betaxolol—glaucoma	8.76e-05	0.000692	CcSEcCtD
Dextroamphetamine—ADRA1B—LPA receptor mediated events—MMP2—glaucoma	8.67e-05	0.00233	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—PTGFR—glaucoma	8.57e-05	0.0023	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—OPN4—glaucoma	8.46e-05	0.00227	CbGpPWpGaD
Dextroamphetamine—Hypersensitivity—Timolol—glaucoma	8.41e-05	0.000665	CcSEcCtD
Dextroamphetamine—SLC6A3—Neuronal System—SLC6A1—glaucoma	8.4e-05	0.00226	CbGpPWpGaD
Dextroamphetamine—Nausea—Betaxolol—glaucoma	8.3e-05	0.000656	CcSEcCtD
Dextroamphetamine—Asthenia—Timolol—glaucoma	8.19e-05	0.000648	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling Pathways—RPTOR—glaucoma	8.04e-05	0.00216	CbGpPWpGaD
Dextroamphetamine—SLC6A3—NRF2 pathway—GSTM1—glaucoma	7.82e-05	0.0021	CbGpPWpGaD
Dextroamphetamine—Diarrhoea—Timolol—glaucoma	7.81e-05	0.000618	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling Pathways—NCK2—glaucoma	7.79e-05	0.00209	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—PTGFR—glaucoma	7.61e-05	0.00205	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	7.58e-05	0.00204	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.56e-05	0.00203	CbGpPWpGaD
Dextroamphetamine—Dizziness—Timolol—glaucoma	7.55e-05	0.000597	CcSEcCtD
Dextroamphetamine—Vomiting—Timolol—glaucoma	7.26e-05	0.000574	CcSEcCtD
Dextroamphetamine—Rash—Timolol—glaucoma	7.2e-05	0.000569	CcSEcCtD
Dextroamphetamine—Dermatitis—Timolol—glaucoma	7.19e-05	0.000569	CcSEcCtD
Dextroamphetamine—Headache—Timolol—glaucoma	7.15e-05	0.000566	CcSEcCtD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.97e-05	0.00187	CbGpPWpGaD
Dextroamphetamine—Nausea—Timolol—glaucoma	6.78e-05	0.000536	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling Pathways—HDAC9—glaucoma	6.62e-05	0.00178	CbGpPWpGaD
Dextroamphetamine—ADRA1B—LPA receptor mediated events—MMP9—glaucoma	6.51e-05	0.00175	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—EDN1—glaucoma	6.37e-05	0.00171	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.17e-05	0.00166	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—EDN1—glaucoma	5.78e-05	0.00155	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—EDN1—glaucoma	5.65e-05	0.00152	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—C3—glaucoma	5.56e-05	0.00149	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—OPN4—glaucoma	5.38e-05	0.00145	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—SMO—glaucoma	5.18e-05	0.00139	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.1e-05	0.00137	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	5.05e-05	0.00136	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—C3—glaucoma	5.05e-05	0.00136	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—GSTT1—glaucoma	5.04e-05	0.00135	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—EDN1—glaucoma	5.02e-05	0.00135	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—OPN4—glaucoma	4.89e-05	0.00131	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PTGFR—glaucoma	4.84e-05	0.0013	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—OPN4—glaucoma	4.78e-05	0.00128	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NTRK2—glaucoma	4.74e-05	0.00127	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.52e-05	0.00121	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	4.49e-05	0.00121	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PTGFR—glaucoma	4.4e-05	0.00118	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—OPN4—glaucoma	4.34e-05	0.00117	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—SMO—glaucoma	4.32e-05	0.00116	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PTGFR—glaucoma	4.3e-05	0.00116	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LRP12—glaucoma	4.16e-05	0.00112	CbGpPWpGaD
Dextroamphetamine—ADRA1B—AMPK Signaling—TP53—glaucoma	4.16e-05	0.00112	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NGFR—glaucoma	4.07e-05	0.00109	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—CYP1B1—glaucoma	4.02e-05	0.00108	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	3.96e-05	0.00106	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PTGFR—glaucoma	3.91e-05	0.00105	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NTRK1—glaucoma	3.86e-05	0.00104	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—SMO—glaucoma	3.84e-05	0.00103	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.74e-05	0.00101	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LRP12—glaucoma	3.7e-05	0.000993	CbGpPWpGaD
Dextroamphetamine—ADRA1A—AMPK Signaling—TP53—glaucoma	3.7e-05	0.000993	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CDKN2B—glaucoma	3.56e-05	0.000956	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CA5A—glaucoma	3.53e-05	0.000949	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NARFL—glaucoma	3.53e-05	0.000949	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—EDN1—glaucoma	3.42e-05	0.000917	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.32e-05	0.000893	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.27e-05	0.000878	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—GSTM1—glaucoma	3.21e-05	0.000863	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	3.17e-05	0.000851	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NGF—glaucoma	3.14e-05	0.000843	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—C3—glaucoma	2.98e-05	0.000801	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.9e-05	0.00078	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—OPN4—glaucoma	2.89e-05	0.000775	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—EDN1—glaucoma	2.85e-05	0.000765	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—APOE—glaucoma	2.78e-05	0.000746	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CAV1—glaucoma	2.75e-05	0.000739	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HEYL—glaucoma	2.68e-05	0.000721	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—FN1—glaucoma	2.62e-05	0.000704	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTGFR—glaucoma	2.6e-05	0.000698	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—BAD—glaucoma	2.59e-05	0.000695	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—OPN4—glaucoma	2.56e-05	0.000689	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—EDN1—glaucoma	2.53e-05	0.00068	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—C3—glaucoma	2.49e-05	0.000669	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HEYL—glaucoma	2.38e-05	0.00064	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTGFR—glaucoma	2.31e-05	0.00062	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—SMO—glaucoma	2.22e-05	0.000596	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—C3—glaucoma	2.21e-05	0.000594	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NOS3—glaucoma	2.08e-05	0.000559	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RPTOR—glaucoma	2.03e-05	0.000546	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—SMO—glaucoma	1.97e-05	0.000529	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NCK2—glaucoma	1.97e-05	0.000529	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RPTOR—glaucoma	1.81e-05	0.000485	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CDKN1B—glaucoma	1.8e-05	0.000484	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NCK2—glaucoma	1.75e-05	0.00047	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CA1—glaucoma	1.73e-05	0.000464	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HDAC9—glaucoma	1.67e-05	0.00045	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CTSA—glaucoma	1.67e-05	0.000449	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MMP9—glaucoma	1.67e-05	0.000448	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—EDN1—glaucoma	1.61e-05	0.000433	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CA2—glaucoma	1.58e-05	0.000424	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—VEGFA—glaucoma	1.5e-05	0.000403	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HDAC9—glaucoma	1.49e-05	0.0004	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—EDN1—glaucoma	1.46e-05	0.000393	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—EDN1—glaucoma	1.43e-05	0.000384	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—C3—glaucoma	1.41e-05	0.000378	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SMO—glaucoma	1.31e-05	0.000352	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—EDN1—glaucoma	1.3e-05	0.000349	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—C3—glaucoma	1.28e-05	0.000343	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—C3—glaucoma	1.25e-05	0.000336	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NTRK2—glaucoma	1.2e-05	0.000322	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SMO—glaucoma	1.16e-05	0.000313	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—C3—glaucoma	1.13e-05	0.000305	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TP53—glaucoma	1.13e-05	0.000304	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TXN—glaucoma	1.11e-05	0.000299	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NTRK2—glaucoma	1.06e-05	0.000286	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NGFR—glaucoma	1.03e-05	0.000276	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NTRK1—glaucoma	9.77e-06	0.000262	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NGFR—glaucoma	9.13e-06	0.000245	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CDKN2B—glaucoma	9e-06	0.000242	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NTRK1—glaucoma	8.68e-06	0.000233	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EDN1—glaucoma	8.64e-06	0.000232	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTT1—glaucoma	8.62e-06	0.000232	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	8e-06	0.000215	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NGF—glaucoma	7.94e-06	0.000213	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EDN1—glaucoma	7.67e-06	0.000206	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—C3—glaucoma	7.55e-06	0.000203	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NGF—glaucoma	7.05e-06	0.000189	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOE—glaucoma	7.03e-06	0.000189	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CAV1—glaucoma	6.96e-06	0.000187	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP1B1—glaucoma	6.87e-06	0.000185	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ABCA1—glaucoma	6.87e-06	0.000185	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—C3—glaucoma	6.7e-06	0.00018	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FN1—glaucoma	6.63e-06	0.000178	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—BAD—glaucoma	6.55e-06	0.000176	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOE—glaucoma	6.24e-06	0.000168	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CAV1—glaucoma	6.18e-06	0.000166	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FN1—glaucoma	5.89e-06	0.000158	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—BAD—glaucoma	5.82e-06	0.000156	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTM1—glaucoma	5.49e-06	0.000148	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOS3—glaucoma	5.26e-06	0.000141	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MTHFR—glaucoma	4.85e-06	0.00013	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOS3—glaucoma	4.68e-06	0.000126	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CDKN1B—glaucoma	4.56e-06	0.000122	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOE—glaucoma	4.52e-06	0.000121	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CAV1—glaucoma	4.48e-06	0.00012	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP9—glaucoma	4.22e-06	0.000113	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	4.05e-06	0.000109	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VEGFA—glaucoma	3.79e-06	0.000102	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP9—glaucoma	3.75e-06	0.000101	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NOS3—glaucoma	3.39e-06	9.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VEGFA—glaucoma	3.37e-06	9.05e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS2—glaucoma	3.1e-06	8.32e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TP53—glaucoma	2.87e-06	7.7e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TP53—glaucoma	2.55e-06	6.84e-05	CbGpPWpGaD
